SRZN Surrozen

Watchlist

11.3000
-0.2200-1.91%

Close Jan 24 16:00 ET

36.72MMarket Cap-0.67P/E (TTM)

About Surrozen Company

Surrozen, Inc. is a clinical stage biotechnology company. It engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K. Christopher Garcia and Roeland Nusse on August 12, 2015 and is headquartered in South San Francisco, CA.

Company Profile

SymbolSRZN

Company NameSurrozen

Listing DateAug 12, 2021

Founded2015

CEOMr. Craig C. Parker

MarketNASDAQ

Employees42

Fiscal Year Ends12-31

Address171 Oyster Point Boulevard,Suite 400

CitySouth San Francisco

ProvinceCalifornia

CountryUnited States of America

Zip Code94080

Phone1-650-489-9000

Websitehttp://www.surrozen.com

Company Executives

Name
Position
Salary

Craig C. Parker
President, Chief Executive Officer and Director
1.17M

Charles Williams
Chief Operating Officer, Chief Financial Officer, Corporate Secretary and Principal Accounting Officer
675.53K

Dr. Yang Li, PhD
Executive Vice President, Research
576.73K

Dr. David J. Woodhouse, PhD
Chairman of the Board
73.05K

Dr. Anna Berkenblit, M.D.
Independent Director
48.05K

Eric H. Bjerkholt
Independent Director
56.94K

Christopher Y. Chai
Independent Director
62.05K

Dr. Shao-Lee Lin, M.D.,PhD
Independent Director
48.05K

Dr. Mace Rothenberg, M.D.
Independent Director
47.05K

Dr. Mary Haak-Frendscho, PhD
Independent Director
53.05K

SRZN Surrozen

About Surrozen Company

Company Profile

Company Executives

Trending Stocks